Evidence map›Paper›PMID 36479799›Full record

ArticleGeriatrics & gerontology international2023

Respiratory sarcopenia: A position paper by four professional organizations.

Susumu Sato, Shinjiro Miyazaki, Akira Tamaki, Yoshihiro Yoshimura, Hidenori Arai, Dai Fujiwara, Hideki Katsura, Atsuyoshi Kawagoshi, Ryo Kozu, Keisuke Maeda and 3 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Geriatrics & gerontology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Respiratory Muscle Strength and Mortality in Patients with COPD: A Systematic Review and Meta-Analysis.International journal of chronic obstructive pulmonary disease · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Repurposing niclosamide to mitigate inflammaging: a review of multi-target mechanisms in cellular senescence and age-related decline.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

Susumu SatoDepartment of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-9626-1090
Shinjiro MiyazakiRehabilitation Center, KKR Takamatsu Hospital, Takamatsu, Japan.ORCID https://orcid.org/0000-0003-1301-2441
Akira TamakiDepartment of Physical Therapy, School of Rehabilitation, Hyogo Medical University, Kobe, Japan.
Yoshihiro YoshimuraCenter for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.ORCID https://orcid.org/0000-0001-7545-4179
Hidenori AraiNational Center for Geriatrics and Gerontology, Obu, Japan.ORCID https://orcid.org/0000-0002-9000-6849
Dai FujiwaraDepartment of Rehabilitation Medicine, Saka General Hospital, Miyagi, Japan.
Hideki KatsuraDepartment of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Atsuyoshi KawagoshiDepartment of Rehabilitation, Akita City Hospital, Akita, Japan.
Ryo KozuDepartment of Physical Therapy Science, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Keisuke MaedaDepartment of Geriatric Medicine, Hospital, National Center for Geriatrics and Gerontology, Obu, Japan.
Sumito OgawaDepartment of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5935-276X
Jun UekiClinical Research Unit of Respiratory Pathophysiology, Graduate School of Health Care and Nursing, Juntendo University, Chiba, Japan.
Hidetaka WakabayashiDepartment of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0364-0818
National Center for Geriatrics and Gerontology · JPAkita University Hospital · JPHyogo University · JPJuntendo University · JPKyoto University · JPNational Hospital Organization Takamatsu Medical Center · JPSaku Central Hospital · JPThe University of Tokyo · JPTokyo Women's Medical University · JPTokyo Women's Medical University Hospital · JPUniversity of Nagasaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and decreased respiratory muscle mass. Although respiratory muscle function is indispensable for life support, its evaluation has not been included in the regular assessment of respiratory function or adequately evaluated in clinical practice. Considering this situation, we prepared a position paper outlining basic knowledge, diagnostic and assessment methods, mechanisms, involvement in respiratory diseases, intervention and treatment methods, and future perspectives on respiratory sarcopenia, and summarized the current consensus on respiratory sarcopenia. Respiratory sarcopenia is diagnosed when respiratory muscle weakness and decreased respiratory muscle mass are observed. If respiratory muscle mass is difficult to measure, we can use appendicular skeletal muscle mass as a surrogate. Probable respiratory sarcopenia is defined when respiratory muscle weakness and decreased appendicular skeletal muscle mass are observed. If only respiratory muscle strength is decreased without a decrease in respiratory function, the patient is diagnosed with possible respiratory sarcopenia. Respiratory muscle strength is assessed using maximum inspiratory pressure and maximum expiratory pressure. Ultrasonography and computed tomography are commonly used to assess respiratory muscle mass; however, there are insufficient data to propose the cutoff values for defining decreased respiratory muscle mass. It was jointly prepared by the representative authors and authorized by the Japanese Society for Respiratory Care and Rehabilitation, Japanese Association on Sarcopenia and Frailty, Japanese Society of Respiratory Physical Therapy and Japanese Association of Rehabilitation Nutrition. Geriatr Gerontol Int 2023; 23: 5-15.

Indexed as

SarcopeniaHumansMuscle, SkeletalMuscle StrengthMuscle WeaknessRespiratory Musclesdiaphragmmusclerehabilitationrespirationsarcopenia

Identifiers

PMID36479799
PMCPMC11503586
OpenAlexW4310964054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.